Lmcg Investments LLC Buys 734 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Lmcg Investments LLC increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.9% during the first quarter, HoldingsChannel.com reports. The firm owned 38,708 shares of the healthcare conglomerate’s stock after acquiring an additional 734 shares during the quarter. UnitedHealth Group makes up approximately 1.3% of Lmcg Investments LLC’s holdings, making the stock its 15th largest holding. Lmcg Investments LLC’s holdings in UnitedHealth Group were worth $20,273,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. Waycross Partners LLC raised its stake in shares of UnitedHealth Group by 2.4% in the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock worth $14,060,000 after purchasing an additional 658 shares during the last quarter. Sherbrooke Park Advisers LLC purchased a new position in UnitedHealth Group in the 4th quarter worth about $515,000. Full Sail Capital LLC boosted its holdings in shares of UnitedHealth Group by 2.1% during the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock valued at $815,000 after acquiring an additional 33 shares during the last quarter. Soros Fund Management LLC bought a new position in UnitedHealth Group during the fourth quarter valued at approximately $39,413,000. Finally, Silvercrest Asset Management Group LLC grew its position in UnitedHealth Group by 47.8% in the 4th quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate’s stock worth $19,625,000 after purchasing an additional 12,550 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 0.3%

Shares of UnitedHealth Group stock opened at $300.37 on Thursday. The company has a fifty day moving average of $418.00 and a 200 day moving average of $488.12. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The company has a market capitalization of $272.48 billion, a P/E ratio of 19.38, a P/E/G ratio of 1.37 and a beta of 0.56. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period last year, the company earned $6.91 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Kristen Gil purchased 3,700 shares of the stock in a transaction that occurred on Thursday, May 15th. The stock was purchased at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the acquisition, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the stock in a transaction that occurred on Wednesday, May 14th. The stock was acquired at an average cost of $320.80 per share, with a total value of $491,786.40. Following the acquisition, the director now owns 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders purchased 109,408 shares of company stock valued at $31,607,768 in the last 90 days. Insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently issued reports on UNH. Royal Bank of Canada dropped their price target on UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating on the stock in a research note on Friday, May 16th. Deutsche Bank Aktiengesellschaft cut their price target on UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating for the company in a research note on Wednesday, May 14th. Mizuho lowered their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a research note on Friday, May 16th. Truist Financial reaffirmed a “buy” rating and set a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Finally, Morgan Stanley cut their price objective on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a research report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $428.43.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.